To help offset the price, both drug manufacturers offer savings programs and patient assistance plans
In a clinical study involving patients with refractory SLEdefined as those with persistent disease activity despite high-dose glucocorticoids and/or cytotoxic drugsthe combination of Low-dose IL-2 (100 WIU, 35 days/month) and rapamycin(0.5 mg every other day) demonstrated synergistic effects (272)
When peptides are blended and timed correctly, they can create a biological chain reaction that multiplies results
Xu, D., Feng, M., Chu, Y., Wang, S., Shete, V., Tuohy, K
Trends in endocrinology and metabolism: TEM, 31(2), 107117
The results for the confirmatory secondary outcomes did not differ significantly between the two groups